Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression

被引:0
作者
Romano, G
Kasten, M
De Falco, G
Micheli, P
Khalili, K
Giordano, A
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Inst, Philadelphia, PA 19107 USA
[3] Azienda Osped Cotugno, Serv Anat Istol & Citol Patol, Naples, Italy
[4] MCP Hahnemann Univ, Ctr Neurovirol & Neurooncol, Philadelphia, PA 19102 USA
关键词
PITALRE; Cdk9; cyclin T1; HIV; Tat; AIDS; antiretroviral therapy; gene therapy;
D O I
10.1002/(SICI)1097-4644(19991201)75:3<357::AID-JCB1>3.0.CO;2-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-1 gene expression relies upon a complex machinery that is primarily controlled by two viral regulatory proteins, Tat and Rev. Rev is involved in regulating post-transcriptional events of HIV-1 gene expression. The Tat protein transactivates transcription from the HIV-1 S' long terminal repeat (LTR) and acts in synergy with specific cellular factors. Recently, it has been shown that one set of these cellular factors is a protein kinase activity termed TAK (Tat-associated kinase), which activates transcription by hyperphosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II. TAK also enhances transcription of HIV-2, together with the retroviral transactivator, Tat-2. The TAK activity appears to be related to the CTD kinase P-TEFb, which stabilizes transcription elongation of many genes and was originally isolated from Drosophila extracts. Both TAK and P-TEFb contain at least two subunits: the cyclin-dependent kinase, CDK9 (PITALRE), the catalytic subunit, and the regulatory subunit, cyclin T1. CDK9 and cyclin T1 are ubiquitous factors that affects many cellular processes, including cell differentiation and apoptosis. The involvement of TAK in HIV-1 and HIV-2 gene expression is an important aspect in the biology of these two retroviruses, and may lead to the development of novel antiretroviral drugs and/or gene therapy approaches for the treatment of patients with AIDS. J. Cell. Biochem. 75:357-368, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 110 条
  • [1] THE HERPES-SIMPLEX VIRUS IMMEDIATE-EARLY PROTEIN, ICP4, IS REQUIRED TO POTENTIATE REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS IN CD4+ LYMPHOCYTES
    ALBRECHT, MA
    DELUCA, NA
    BYRN, RA
    SCHAFFER, PA
    HAMMER, SM
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (05) : 1861 - 1868
  • [2] TRANSMISSION OF ZIDOVUDINE-RESISTANT HIV-1 THROUGH HETEROSEXUAL CONTACTS
    ANGARANO, G
    MONNO, L
    APPICE, A
    GIANNELLI, A
    ROMANELLI, C
    FICO, C
    PASTORE, G
    [J]. AIDS, 1994, 8 (07) : 1013 - 1014
  • [3] REGULATION OF TRANSCRIPTIONAL ELONGATION BY RNA-POLYMERASE-II
    BENTLEY, DL
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (02) : 210 - 216
  • [4] TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET
    BERKHOUT, B
    SILVERMAN, RH
    JEANG, KT
    [J]. CELL, 1989, 59 (02) : 273 - 282
  • [5] Synergistic enhancement of both initiation and elongation by acidic transcription activation domains
    Blair, WS
    Fridell, RA
    Cullen, BR
    [J]. EMBO JOURNAL, 1996, 15 (07) : 1658 - 1665
  • [6] Blau J, 1996, MOL CELL BIOL, V16, P2044
  • [7] HIV-1 IN THE DEVELOPING CNS - DEVELOPMENTAL DIFFERENCES IN GENE-EXPRESSION
    BUZY, JM
    LINDSTROM, LM
    ZINK, MC
    CLEMENTS, JE
    [J]. VIROLOGY, 1995, 210 (02) : 361 - 371
  • [8] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel
    Carpenter, CCJ
    Fischl, MA
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schooley, RT
    Thompson, MA
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969
  • [9] Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
    Cavert, W
    Notermans, DW
    Staskus, K
    Wietgrefe, SW
    Zupancic, M
    Gebhard, K
    Henry, K
    Zhang, ZQ
    Mills, R
    McDade, H
    Goudsmit, J
    Danner, SA
    Haase, AT
    [J]. SCIENCE, 1997, 276 (5314) : 960 - 964
  • [10] A RECOMBINANT HIV PROVIRUS IS SYNERGISTICALLY ACTIVATED BY THE HIV TAT PROTEIN AND THE HSV-IE1 PROTEIN BUT NOT BY THE HSV-IE3 PROTEIN
    CHAPMAN, CJ
    HARRIS, JD
    COLLINS, MKL
    LATCHMAN, DS
    [J]. AIDS, 1991, 5 (08) : 945 - 950